First Trust Advisors
KZR

First Trust Advisors’s Kezar Life Sciences KZR Stock Holding History

First Trust Advisors’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,646
Closed -$524K – 2579
2021
Q2 		$524K Buy
9,646
+31
+0.3% +$1.76K ﹤0.01% 2269
2021
Q1 		$573K Buy
9,615
+772
+9% +$45.1K ﹤0.01% 2174
2020
Q4 		$462K Sell
8,843
-398
-4% -$22.1K ﹤0.01% 2135
2020
Q3 		$447K Buy
+9,241
New +$442K ﹤0.01% 2070

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors's KZR Position: Q3 2021 in Review

First Trust Advisors sold out of Kezar Life Sciences (KZR) in Q3 2021, closing a stake of 9,646 shares — an estimated $524K sold.

First Trust Advisors first reported a position in KZR in Q3 2020 and held it in 4 quarters. The position peaked at $573K in Q1 2021. 76 funds tracked by Wall St. Rank hold KZR as of Q3 2021.

  • First Trust Advisors reported no remaining Kezar Life Sciences position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 9,646 Kezar Life Sciences shares in Q3 2021, an estimated $524K.
  • First Trust Advisors first reported a position in Kezar Life Sciences in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Kezar Life Sciences position peaked at $573K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.